ANTERIS TECHNOLOGIES LTD Anteris Technologies Ltd Share Price
Equities
AVR
AU0000088841
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.75 AUD | -1.09% |
|
-1.09% | +18.80% |
| 18/04 | Anteris Technologies Posts AU$10.6 Million Cash, AU$20.2 Million Net Cash Outflows for Quarter Ended March 31 | MT |
| 10/04 | Anteris Technologies Raises AU$23 Million for DurAVR Study | MT |
| Sales 2024 * | 6M 3.92M 327M | Sales 2025 * | 6M 3.92M 327M | Capitalization | 437M 285M 23.8B |
|---|---|---|---|---|---|
| Net income 2024 * | -79M -51.6M -4.3B | Net income 2025 * | -85M -55.52M -4.63B | EV / Sales 2024 * | 68.7 x |
| Net cash position 2024 * | 25M 16.33M 1.36B | Net cash position 2025 * | 25M 16.33M 1.36B | EV / Sales 2025 * | 68.7 x |
| P/E ratio 2024 * |
-6.12
x | P/E ratio 2025 * |
-6.5
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.75% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.09% | ||
| 1 week | -1.09% | ||
| Current month | -3.11% | ||
| 1 month | +1.34% | ||
| 3 months | +40.52% | ||
| 6 months | +10.98% | ||
| Current year | +18.80% |
1 week
22.50
23.45
1 month
22.5023.93
Current year
15.5823.93
1 year
15.5824.38
3 years
6.8030.89
5 years
3.0130.89
10 years
2.90170.00
| Managers | Title | Age | Since |
|---|---|---|---|
Wayne Paterson
CEO | Chief Executive Officer | 56 | 10/14/10 |
| Director of Finance/CFO | - | 23/18/23 | |
Chris Meduri
CTO | Chief Tech/Sci/R&D Officer | - | 06/21/06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
John Seaberg
CHM | Chairman | 72 | 10/14/10 |
Stephen Denaro
BRD | Director/Board Member | - | 31/18/31 |
Wayne Paterson
CEO | Chief Executive Officer | 56 | 10/14/10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 22.75 | -1.09% | 5,075 |
| 24/24/24 | 23 | -0.43% | 7,785 |
| 23/24/23 | 23.1 | 0.00% | 3,802 |
| 22/24/22 | 23.1 | +0.43% | 3,130 |
| 19/24/19 | 23 | -1.67% | 22,699 |
Delayed Quote Australian S.E., April 26, 2024 at 11:40 am IST
More quotes
Anteris Technologies Ltd is an Australia-based company that is engaged in the research and development (R&D) of its structural heart products. The Company is engaged in the manufacture and sale of ADAPT regenerative tissue products globally. It is focused on developing biomimetic transcatheter aortic valve replacement (TAVR) for the treatment of aortic stenosis. ADAPT is the Companyâs patented anti-calcification tissue technology. Its DurAVR THV is a three dimensional (3D) single piece valve and is a biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The Company also provides ComASUR Delivery System, a balloon expandable system with the ability to rotate valves for predictable alignment with the heartâs native commissure.
Calendar
29/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
22.75
AUD
Average target price
30
AUD
Spread / Average Target
+31.87%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +18.80% | 285M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- AVR Stock
